Article Information
History
- September 12, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yujie Chen1,8,
- Jingxin Li2,8,
- Davone Duangdany3,
- Chanthala Phamisith4,
- Bo Yu1,
- Shengke Lan1,
- Lairun Jin2,
- Dawei Lv1,
- Yang Li1,
- Bin Luo1,
- Peng Han1,
- Jinyan Wu1,
- Yuzhu Wang1,
- Congcong Xu1,
- Mingyun Shen1,
- Fanfan Zhao1,
- Peipei Liu5,
- Rongjuan Pei6,
- Haifa Shen1,
- Wuxiang Guan6,*,9,
- Hangwen Li1,*,9 and
- Mayfong Mayxay7,*,9
- 1Stemirna Therapeutics, Shanghai, China
- 2Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China
- 3Food and Drug Department, Ministry of Health, Vientiane, Laos
- 4Savannakhet Province Hospital, Savannakhet, Laos
- 5Chinese center for disease control and prevention, China
- 6Wuhan Institute of Virology, Wuhan, China
- 7Institute of Research and Education Development, University of Health Sciences, Vientiane, Lao People’s Democratic Republic
- ↵*Correspondence to:
Wuxiang Guan, guanwx{at}wh.iov.cn, Hangwen Li, lihangwen{at}stemirna.com, Mayfong Mayxay, mayfong{at}tropmedres.ac